Rathbones Group PLC Astrazeneca PLC Transaction History
Rathbones Group PLC
- $19.7 Billion
- Q4 2024
A detailed history of Rathbones Group PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Rathbones Group PLC holds 11,991 shares of AZN stock, worth $929,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,991
Previous 13,703
12.49%
Holding current value
$929,302
Previous $1.07 Million
26.43%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,366Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.68 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.18 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.91 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.87 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.86 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...